DJ Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 3.10% to $1.25 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.13% to 26,936.04 and Dow Jones Industrial Average falling 0.68% to 51,511.59.
Inovio Pharmaceuticals Inc. closed 54.04% below its 52-week high of $2.72, which the company reached on December 17th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.01% to $269.17, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.90% to $28.18.
Trading volume (3.0 M) remained 1.2 million below its 50-day average volume of 4.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.
Comments